GSK Investigational Site

Athens, Georgia 30607

0 studies enrolling now · 8 studies all time

What they study most

Diabetes Mellitus, Type 2, Herpes Simplex Infection, Lung Cancer, Non-Small Cell, Lung Cancer, Small Cell, Melanoma, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Pulmonary Disease, Chronic Obstructive, Recurrent Small-cell Lung Cancer (SCLC)

Studies at this site

• Phase 2b Study of GSK4532990 in Adults With NASH — Running, not enrolling
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• HerpeVac Trial for Young Women — Completed
• GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma — Completed
• Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only — Completed
• An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer — Completed
• Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer — Completed